Although most cases of CRC are initiated by Wnt pathway mutations resulting in increased levels of transcriptionally active beta-catenin, butyrate up-regulates Wnt activity and apoptosis in colonic cells in part by stimulating Wnt signalling upstream of beta-catenin, at the ligand-receptor level [5]. The gene discussed is CTNNB1; the disease is colorectal carcinoma.